These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31138373)

  • 1. An Isolated Method and Assignment for Critical Impurities in Semi-Synthetic Process of Arbekacin Sulfate.
    Chen ZH; Zhou H; Wang S; Li G; Zhang J; Wang F; Li C; Qiao RZ
    Pharmazie; 2019 Jun; 74(6):352-356. PubMed ID: 31138373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of impurity profiling of arbekacin sulfate by ion-pair liquid chromatography coupled with pulsed electrochemical detection and online ion suppressor-ion trap-time off light mass spectrometry.
    Chen Z; Zhu X; Geng Y; Dai J; Tang S; Adams E; Chen D; Yuan Y
    J Pharm Biomed Anal; 2022 Nov; 221():115061. PubMed ID: 36183632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and structure characterization of related impurities in etimicin sulfate by LC/ESI-MS(n) and NMR.
    Wang H; Zhang Z; Xiong F; Wu L; Li P; Ye W
    J Pharm Biomed Anal; 2011 Jul; 55(5):902-7. PubMed ID: 21444173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and structure characterization of related impurities in etimicin intermediate P1 by LC/ESI-MS(n) and NMR.
    Wang Y; Zhang Z; Wu L; Zhang X; Wang H; Ye W; Li P
    J Pharm Biomed Anal; 2014 Aug; 97():97-102. PubMed ID: 24858300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
    Prajapati KJ; Kothari CS
    Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, isolation and characterization of process related impurities in ezetimibe.
    Guntupalli S; Ray UK; Murali N; Gupta PB; Kumar VJ; Satheesh D; Islam A
    J Pharm Biomed Anal; 2014 Jan; 88():385-90. PubMed ID: 24176742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of 5-deoxy-5-episubstituted arbekacin derivatives.
    Hiraiwa Y; Usui T; Akiyama Y; Maebashi K; Minowa N; Ikeda D
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3540-3. PubMed ID: 17502146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four process-related potential new impurities in ticagrelor: Identification, isolation, characterization using HPLC, LC/ESI-MS(n), NMR and their synthesis.
    Kumar N; Devineni SR; Gajjala PR; Gupta DK; Bhat S; Kumar R; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2016 Feb; 120():248-60. PubMed ID: 26760243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, identification and characterization of novel process-related impurities in flupirtine maleate.
    Zhang D; Song X; Su J
    J Pharm Biomed Anal; 2014 Mar; 90():27-34. PubMed ID: 24333703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of impurities in semi-synthetic vinorelbine bitartrate by HPLC-MS with mass spectrometric shift technique.
    Cao X; Tai Y; Sun C; Wang K; Pan Y
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):39-45. PubMed ID: 16085133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial activity of 4″ or 6″-alkanoylamino derivatives of arbekacin.
    Sasaki K; Kobayashi Y; Kurihara T; Yamashita Y; Takahashi Y; Miyake T; Akamatsu Y
    J Antibiot (Tokyo); 2015 Dec; 68(12):741-7. PubMed ID: 25990952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study.
    Nageswara Rao R; Narasa Raju A; Narsimha R
    J Pharm Biomed Anal; 2008 Feb; 46(3):505-19. PubMed ID: 18162355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation, identification, characterization, synthesis and quality control strategy of new process-related impurities in ambrisentan.
    Feng WD; Zhuo SM; Zhang FL
    J Pharm Biomed Anal; 2019 Feb; 165():325-337. PubMed ID: 30579233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel enzymatic 3''-N-acetylation of arbekacin by an aminoglycoside 3-N-acetyltransferase of Streptomyces origin and the resulting activity.
    Hotta K; Sunada A; Ishikawa J; Mizuno S; Ikeda Y; Kondo S
    J Antibiot (Tokyo); 1998 Aug; 51(8):735-42. PubMed ID: 9766465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid quantification of the aminoglycoside arbekacin in serum using high performance liquid chromatography-tandem mass spectrometry.
    Breaud AR; Henemyre-Harris CL; Schools S; Emezienna N; Clarke W
    Clin Chim Acta; 2013 Mar; 418():102-6. PubMed ID: 23333924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impurities of anxiolytic drug, clobazam: Identification, synthesis and characterization using HPLC, LC-ESI/MS
    Kumar N; Devineni SR; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2017 Apr; 137():268-278. PubMed ID: 28183048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of varying the 4''-position of arbekacin derivatives on antibacterial activity against MRSA and Pseudomonas aeruginosa.
    Hiraiwa Y; Minowa N; Usui T; Akiyama Y; Maebashi K; Ikeda D
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6369-72. PubMed ID: 17889537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of the impurities during the manufacture of bulk drug midazolam and separation of these impurities by HPLC.
    Sati B; Sati H; Saklani S; ; Bhatt PC; Mishra R
    Acta Pharm; 2013 Sep; 63(3):385-96. PubMed ID: 24152898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.